The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


PARIET 20 mg gastro-resistant tablet

20 milligram(s) Gastro-resistant tablet

Janssen Sciences Ireland UCPA22612/009/002

Main Information

Trade NamePARIET 20 mg gastro-resistant tablet
Active SubstancesRabeprazole sodium
Strength20 milligram(s)
Dosage FormGastro-resistant tablet
Licence HolderJanssen Sciences Ireland UC
Licence NumberPA22612/009/002

Group Information

ATC CodeA02BC Proton pump inhibitors
A02BC04 rabeprazole

Status

Authorised/WithdrawnAuthorised
Licence Issued30/10/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0015-003-005
Interchangeable List DocumentPDF of Interchangeable List
« Back